+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Microfluidic Devices Market Report and Forecast 2023-2031

  • PDF Icon


  • 147 Pages
  • May 2023
  • Region: Global
  • Expert Market Research
  • ID: 5805830
The global Microfluidic devices market value was USD 11.3 billion in 2022, driven by the increasing demand for point-of-care testing across the globe. The market size is anticipated to grow at a CAGR of 20.7% during the forecast period of 2023-2031 to achieve a value of USD 60.8 billion by 2031.


Microfluidic devices, also known as lab-on-a-chip or micro-total analysis systems, are miniaturized platforms that integrate various laboratory functions onto a single microscale device. These devices enable precise manipulation and control of small volumes of fluids, typically in the range of microliters to nanoliters. Microfluidic technology has revolutionized many areas of research and industry, including healthcare diagnostics, pharmaceutical development, chemical analysis, environmental monitoring, and more.

The key advantage of microfluidic devices lies in their ability to perform complex laboratory tasks with minimal sample and reagent consumption, reduced cost, and faster analysis times. The miniaturized nature of these devices allows for improved control over fluid flow, precise mixing, and the ability to generate high-throughput and parallelized experiments. Additionally, microfluidic devices offer the potential for integration with other analytical techniques, such as optical detection methods and sensors.

Microfluidic devices have found widespread applications in various fields. In healthcare, they are used for point-of-care diagnostics, DNA sequencing, drug delivery systems, and organ-on-a-chip models for drug testing. In the chemical and biological research fields, microfluidics enables rapid prototyping and optimization of experiments, as well as the study of cellular behaviors and interactions.

Key Trends in the Microfluidic devices Market

Some key trends involved in the microfluidic devices market are as follows:
  • Growing Demand for Controlled Release Systems: The pharmaceutical industry is increasingly adopting microencapsulation techniques to develop controlled release drug delivery systems. These systems allow for precise control over the release rate and duration of active ingredients, leading to improved therapeutic outcomes and patient compliance
  • Expansion of the Food and Beverage Industry: Microencapsulation is widely used in the food and beverage industry to enhance the flavor, texture, and stability of products. It is used to encapsulate flavors, vitamins, probiotics, and other sensitive ingredients, allowing for their targeted delivery and protection during processing and storage
  • Increasing Focus on Personalized and Functional Cosmetics: Microencapsulation is gaining traction in the cosmetics industry, particularly in the development of personalized and functional products. Encapsulation of active ingredients in cosmetics helps improve their stability, bioavailability, and targeted delivery to the skin, resulting in enhanced efficacy and consumer satisfaction
  • Advancements in Encapsulation Techniques: The field of microencapsulation is witnessing continuous advancements in encapsulation techniques, materials, and processing methods. These advancements enable the development of novel encapsulation systems with improved efficiency, scalability, and versatility. Examples include spray drying, coacervation, fluidized bed coating, and electrostatic encapsulation

Microfluidic devices Market Segmentations

Market Breakup by Product Type

  • Microfluidic-Based Devices

Microfluidic Components

  • Microfluidic Chips
  • Flow and Pressure Sensors
  • Microfluidic Valves
  • Micropumps
  • Microneedles
  • Other Components

Market Breakup by Material

  • Glass
  • Silicon
  • Polymer
  • Others

Market Breakup by Applications

  • Pharmaceutical & Life Sciences Research
  • Point of Care Testing
  • Drug Delivery
  • Analytical Devices
  • Clinical and Veterinary Diagnostics
  • Environment and Industrial
  • Others

Market Breakup by End User

  • Hospitals & Diagnostic Centers
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Others

Market Breakup by Region

North America

  • United States of America
  • Canada


  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • Others

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Others

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Microfluidic devices Market Scenario

The microfluidic devices market is experiencing significant growth due to advancements in microfluidic technology and its wide range of applications in various industries. Microfluidic devices are miniaturized systems that manipulate and control fluids at the microliter or nanoliter scale, enabling precise and efficient analysis, testing, and experimentation.

In the healthcare industry, microfluidic devices have revolutionized diagnostics, drug discovery, and personalized medicine. These devices enable the rapid and accurate detection of diseases, such as infectious diseases and cancer, through the miniaturization of laboratory processes. Microfluidic devices also play a crucial role in drug discovery by facilitating high-throughput screening, improving efficiency, and reducing costs. Furthermore, they enable the development of point-of-care diagnostic devices, providing quick and convenient testing options for patients.

The academic and research sector also extensively uses microfluidic devices for various applications, including cell analysis, molecular biology, genomics, proteomics, and tissue engineering. The precise control of fluids and the ability to create complex microenvironments within these devices have opened new avenues for scientific research and experimentation.

The market for microfluidic devices is driven by factors such as the increasing demand for point-of-care testing, rising adoption of personalized medicine, technological advancements in microfluidics, and growing research and development activities. Additionally, the growing need for portable and easy-to-use diagnostic devices in resource-limited settings further fuels the market growth.

Microfluidic devices Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • Parker-Hannifin Corporation
  • Agilent Technologies, Inc
  • Standard BioTools
  • Fluigent S.A
  • ALine Inc,
  • Blacktrace Holdings Ltd
  • Fluidigm Corporation
  • Bio-Rad Laboratories, Inc
  • F. Hoffmann-La Roche Ltd

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Microfluidic Devices Market Overview
3.1 Global Microfluidic Devices Market Historical Value (2016-2022)
3.2 Global Microfluidic Devices Market Forecast Value (2023-2031)
4 Global Microfluidic Devices Market Landscape
4.1 Global Microfluidic Devices Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Microfluidic Devices Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Applications
4.2.3 Analysis by End User
5 Global Microfluidic Devices Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Microfluidic Devices Market Segmentation
6.1 Global Microfluidic Devices Market by Product Type
6.1.1 Market Overview
6.1.2 Microfluidic-Based Devices
6.1.3 Microfluidic Components Microfluidic Chips Flow and Pressure Sensors Microfluidic Valves Micropumps Microneedles Other Components
6.2 Global Microfluidic Devices Market by Material
6.2.1 Market Overview
6.2.2 Glass
6.2.3 Silicon
6.2.4 Polymer
6.2.5 Others
6.3 Global Microfluidic Devices Market by Application
6.3.1 Market Overview
6.3.2 Pharmaceutical & Life Sciences Research
6.3.3 Point of Care Testing
6.3.4 Drug Delivery
6.3.5 Analytical Devices
6.3.6 Clinical and Veterinary Diagnostics
6.3.7 Environment and Industrial
6.3.8 Others
6.4 Global Microfluidic Devices Market by End User
6.4.1 Market Overview
6.4.2 Hospitals & Diagnostic Centers
6.4.3 Academic & Research Institutes
6.4.4 Pharmaceutical & Biotechnology Companies
6.4.5 Others
6.5 Global Microfluidic Devices Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Microfluidic Devices Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Microfluidic Devices Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Microfluidic Devices Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.6 Australia
9.7 Others
10 Latin America Microfluidic Devices Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Microfluidic Devices Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.5 Others
17 Supplier Landscape
17.1 Parker-Hannifin Corporation
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Agilent Technologies, Inc.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Standard BioTools
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Fluigent S.A.
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 ALine Inc,
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Blacktrace Holdings Ltd.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Fluidigm Corporation
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Bio-Rad Laboratories, Inc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 F. Hoffmann-La Roche Ltd
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
18 Global Microfluidic Devices Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Companies Mentioned

  • Parker-Hannifin Corporation
  • Agilent Technologies Inc.
  • Standard BioTools
  • Fluigent S.A.
  • ALine Inc,
  • Blacktrace Holdings Ltd.
  • Fluidigm Corporation
  • Bio-Rad Laboratories Inc.
  • F. Hoffmann-La Roche Ltd



Table Information